| NCT03345485 |
Study of the Safety, Pharmacokinetics and Efficacy of EDO-S101, in Patients With Advanced Solid Tumors |
https://ClinicalTrials.gov/show/NCT03345485 |
Active, not recruiting |
Mundipharma-EDO GmbH |
2021-12-31 |
| NCT04456972 |
Reliability and Interest of Circulating Tumor DNA in Endometrial Cancers. |
https://ClinicalTrials.gov/show/NCT04456972 |
Recruiting |
Poitiers University Hospital |
2021-06-16 |
| NCT04214067 |
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to the Usual Radiation Treatment for Newly Diagnosed Early Stage High Intermediate Risk Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT04214067 |
Recruiting |
National Cancer Institute (NCI) |
2024-02-01 |
| NCT04205864 |
Application of Thrombin Gel Matrix for the Prevention of Lymphocele in Patients With Endometrial Cancer. |
https://ClinicalTrials.gov/show/NCT04205864 |
Completed |
Kocaeli University |
2020-07-01 |
| NCT04205630 |
SYD985 in Patients With HER2-expressing Recurrent, Advanced or Metastatic Endometrial Carcinoma |
https://ClinicalTrials.gov/show/NCT04205630 |
Recruiting |
Byondis B.V. |
2022-04-30 |
| NCT03324958 |
VIrtual REality Glasses for the Enhancement of Acute BRACHYtherapy Tolerance for Endometrial Cancer Patients. |
https://ClinicalTrials.gov/show/NCT03324958 |
Recruiting |
Institut de Cancérologie de la Loire |
2021-02-01 |
| NCT03395080 |
A Study of DKN-01 as a Monotherapy or in Combination With Paclitaxel in Patients With Recurrent Epithelial Endometrial or Epithelial Ovarian Cancer or Carcinosarcoma |
https://ClinicalTrials.gov/show/NCT03395080 |
Active, not recruiting |
Leap Therapeutics, Inc. |
2020-06-30 |
| NCT03394027 |
ONC201 in Recurrent/Refractory Metastatic Breast Cancer and Advanced Endometrial Carcinoma |
https://ClinicalTrials.gov/show/NCT03394027 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
2022-08-01 |
| NCT03372720 |
Fractional CO2 Laser Therapy in Minimizing Genitourinary Syndrome of Menopause in Gynecological Cancer Survivors |
https://ClinicalTrials.gov/show/NCT03372720 |
Active, not recruiting |
Ohio State University Comprehensive Cancer Center |
2019-12-18 |
| NCT03367923 |
Health and Recovery Program in Increasing Physical Activity Level in Stage IA-IIIA Endometrial Cancer Survivors |
https://ClinicalTrials.gov/show/NCT03367923 |
Active, not recruiting |
Stanford University |
2020-04-01 |
| NCT03366480 |
A Study to Assess the Efficacy and Safety of ABTL0812 |
https://ClinicalTrials.gov/show/NCT03366480 |
Recruiting |
Ability Pharmaceuticals SL |
2020-06-01 |
| NCT03832361 |
Evaluation of Mirvetuximab Soravtansine (IMGN853) in Women With Folate Receptor-α Positive Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT03832361 |
Recruiting |
Yale University |
2023-10-31 |
| NCT03722030 |
Telehealth-Based Resistance Training Intervention for Endometrial Cancer Survivors |
https://ClinicalTrials.gov/show/NCT03722030 |
Completed |
University of Wisconsin, Madison |
2020-03-14 |
| NCT03366051 |
Sentinel Node Mapping in High Risk Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT03366051 |
Recruiting |
AC Camargo Cancer Center |
2021-12-20 |
| NCT03820024 |
MOtiVating Endometrial Cancer Survivors With Activity Monitors and Tailored Feedback |
https://ClinicalTrials.gov/show/NCT03820024 |
Active, not recruiting |
UNC Lineberger Comprehensive Cancer Center |
2019-12-23 |
| NCT03339843 |
Multiorgan Metabolic Imaging Response Assessment of Abemaciclib |
https://ClinicalTrials.gov/show/NCT03339843 |
Recruiting |
Jules Bordet Institute |
2021-10-15 |
| NCT03339765 |
Self-Advocacy Serious Game in Advanced Cancer |
https://ClinicalTrials.gov/show/NCT03339765 |
Recruiting |
University of Pittsburgh |
2022-04-30 |
| NCT03314935 |
A Phase 1/2 Study of INCB001158 in Combination With Chemotherapy in Subjects With Solid Tumors |
https://ClinicalTrials.gov/show/NCT03314935 |
Recruiting |
Incyte Corporation |
2021-10-06 |
| NCT03300557 |
Exemestane in Treating Patients With Complex Atypical Hyperplasia of the Endometrium/Endometrial Intraepithelial Neoplasia or Low Grade Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT03300557 |
Recruiting |
National Cancer Institute (NCI) |
2021-12-01 |
| NCT03285152 |
A Study of Ketogenic Diet in Newly Diagnosed Overweight or Obese Endometrial Cancer Patients |
https://ClinicalTrials.gov/show/NCT03285152 |
Recruiting |
Memorial Sloan Kettering Cancer Center |
2021-08-11 |
| NCT03277482 |
Durvalumab, Tremelimumab + Radiotherapy in Gynecologic Cancer |
https://ClinicalTrials.gov/show/NCT03277482 |
Recruiting |
Dana-Farber Cancer Institute |
2021-01-01 |
| NCT03276013 |
Pembrolizumab in Combination With Doxorubicin in Advanced, Recurrent or Metastatic Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT03276013 |
Active, not recruiting |
Vall d’Hebron Institute of Oncology |
2020-06-01 |
| NCT03270995 |
Cognitive-Existential Group Therapy to Reduce Fear of Cancer Recurrence: A RCT Study |
https://ClinicalTrials.gov/show/NCT03270995 |
Completed |
McGill University |
2020-02-01 |
| NCT03245736 |
Tisotumab Vedotin Continued Treatment in Patients With Solid Tumors. |
https://ClinicalTrials.gov/show/NCT03245736 |
Completed |
Genmab |
2019-01-10 |
| NCT03241914 |
Megestrol Acetate Plus LNG-IUS in Young Women With Early Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT03241914 |
Recruiting |
Fudan University |
2020-07-03 |
| NCT03241745 |
A Study of Nivolumab in Selected Uterine Cancer Patients |
https://ClinicalTrials.gov/show/NCT03241745 |
Recruiting |
Memorial Sloan Kettering Cancer Center |
2021-08-31 |
| NCT03212404 |
Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced Cancers |
https://ClinicalTrials.gov/show/NCT03212404 |
Recruiting |
Checkpoint Therapeutics, Inc. |
2021-07-31 |
| NCT03210129 |
Motivational Interviewing to Increase Physical Activity Behaviour in Cancer Patients |
https://ClinicalTrials.gov/show/NCT03210129 |
Completed |
Luxembourg Institute of Health |
2019-02-28 |
| NCT03207126 |
Pilot Study: Can Ultrasound Guided Biopsy be Used as an Alternative to Hysteroscopy? |
https://ClinicalTrials.gov/show/NCT03207126 |
Recruiting |
Imperial College London |
2020-12-20 |
| NCT03207074 |
Can the iKnife Distinguish Between Normal and Malignant Endometrial Tissue? |
https://ClinicalTrials.gov/show/NCT03207074 |
Completed |
Imperial College London |
2019-06-20 |
| NCT03207061 |
Can 3D Ultrasound be Used as an Alternative to MRI to Assess Myometrial Invasion in Endometrial Cancer? |
https://ClinicalTrials.gov/show/NCT03207061 |
Recruiting |
Imperial College London |
2020-12-01 |
| NCT03192059 |
Study of Pembrolizumab, Radiation and Immune Modulatory Cocktail in Cervical/Uterine Cancer |
https://ClinicalTrials.gov/show/NCT03192059 |
Recruiting |
University Hospital, Ghent |
2021-06-30 |
| NCT03189446 |
Vaginal Cuff Brachytherapy Followed by Chemotherapy in Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT03189446 |
Active, not recruiting |
University of Oklahoma |
2022-06-01 |
| NCT03184350 |
Adjuvant Protontherapy of Cervical and Endometrial Carcinomas |
https://ClinicalTrials.gov/show/NCT03184350 |
Recruiting |
Heidelberg University |
2019-06-30 |
| NCT03171506 |
Targeted Disruption to Cancer Metabolism and Growth Through Dietary Macronutrient Modification |
https://ClinicalTrials.gov/show/NCT03171506 |
Completed |
University of Alabama at Birmingham |
2017-07-18 |
| NCT03170960 |
Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors |
https://ClinicalTrials.gov/show/NCT03170960 |
Recruiting |
Exelixis |
2020-12-31 |
| NCT03149549 |
PROCLAIM-CX-2009: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2009 for Patients With Selected Solid Tumors |
https://ClinicalTrials.gov/show/NCT03149549 |
Recruiting |
CytomX Therapeutics |
2019-12-31 |
| NCT03120624 |
VSV-hIFNbeta-NIS in Treating Patients With Stage IV or Recurrent Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT03120624 |
Recruiting |
Mayo Clinic |
2020-06-01 |
| NCT03099499 |
Single Agent ONC201 in Recurrent or Metastatic Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT03099499 |
Recruiting |
Fox Chase Cancer Center |
2021-10-01 |
| NCT03095664 |
Effect of a Lifestyle Intervention on Nutritional Status and Prognosis of Endometrial Cancer Survivors |
https://ClinicalTrials.gov/show/NCT03095664 |
Recruiting |
Brazilian National Cancer Institute |
2023-11-30 |
| NCT03077698 |
An Endometrial Cancer Study for Women With Recurrent or Persistent Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT03077698 |
Active, not recruiting |
Xenetic Biosciences, Inc. |
2021-01-31 |
| NCT03042897 |
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT03042897 |
Recruiting |
University of Southern California |
2020-09-08 |
| NCT03015129 |
A Study of Durvalumab With or Without Tremelimumab in Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT03015129 |
Active, not recruiting |
Memorial Sloan Kettering Cancer Center |
2021-01-31 |
| NCT03008408 |
Study of Ribociclib (LEE011), Everolimus, and Letrozole, in Patients With Advanced or Recurrent Endometrial Carcinoma |
https://ClinicalTrials.gov/show/NCT03008408 |
Recruiting |
M.D. Anderson Cancer Center |
2022-08-31 |
| NCT02997553 |
Fluorescence for Sentinel Lymph Node Identification in Cancer Surgery |
https://ClinicalTrials.gov/show/NCT02997553 |
Recruiting |
Institut de Cancérologie de Lorraine |
2022-11-30 |
| NCT02988817 |
Enapotamab Vedotin (HuMax-AXL-ADC) Safety Study in Patients With Solid Tumors |
https://ClinicalTrials.gov/show/NCT02988817 |
Recruiting |
Genmab |
2021-02-28 |
| NCT02987881 |
Endometrial Cancer Diet and Exercise |
https://ClinicalTrials.gov/show/NCT02987881 |
Completed |
Duke University |
2019-06-01 |
| NCT02983279 |
Caloric Restriction Before Surgery in Treating Patients With Endometrial, Prostate, or Breast Cancer |
https://ClinicalTrials.gov/show/NCT02983279 |
Active, not recruiting |
Thomas Jefferson University |
2021-10-27 |
| NCT02977195 |
First in Human Evaluation of Safety, Pharmacokinetics, and Clinical Activity of a Monoclonal Antibody Targeting Netrin 1 in Patients With Advanced/Metastatic Solid Tumors |
https://ClinicalTrials.gov/show/NCT02977195 |
Recruiting |
Centre Leon Berard |
2020-11-30 |
| NCT02914470 |
Carboplatin-cyclophosphamide Combined With Atezolizumab |
https://ClinicalTrials.gov/show/NCT02914470 |
Active, not recruiting |
The Netherlands Cancer Institute |
2017-08-31 |
| NCT02912572 |
Avelumab in Patients With MSS, MSI-H and POLE-mutated Recurrent or Persistent Endometrial Cancer and of Avelumab/Talazoparib and Avelumab/Axitinib in Patients With MSS Recurrent or Persistent Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT02912572 |
Recruiting |
Dana-Farber Cancer Institute |
2021-10-31 |
| NCT02899793 |
Pembrolizumab in Ultramutated and Hypermutated Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT02899793 |
Active, not recruiting |
Yale University |
2020-12-31 |
| NCT02807844 |
Phase Ib/II Study of MCS110 in Combination With PDR001 in Patients With Advanced Malignancies |
https://ClinicalTrials.gov/show/NCT02807844 |
Active, not recruiting |
Novartis |
2020-04-28 |
| NCT02788708 |
Lenvatinib and Weekly Paclitaxel for Patients With Recurrent Endometrial or Ovarian Cancer |
https://ClinicalTrials.gov/show/NCT02788708 |
Active, not recruiting |
Ohio State University Comprehensive Cancer Center |
2019-11-30 |
| NCT02774759 |
Feasibility of the NEXT Steps Weight Loss Intervention +/- Resistance Training for Endometrial Cancer Survivors: Effect on Lean Mass & Biomarkers |
https://ClinicalTrials.gov/show/NCT02774759 |
Active, not recruiting |
M.D. Anderson Cancer Center |
2020-10-31 |
| NCT02755844 |
Safety and Efficacy of Metronomic Cyclophosphamide, Metformin and Olaparib in Endometrial Cancer Patients |
https://ClinicalTrials.gov/show/NCT02755844 |
Active, not recruiting |
Hospices Civils de Lyon |
2018-11-30 |
| NCT02744898 |
A Phase 2 Feasibility Study of Abraxane and Carboplatin in Epithelial Neoplasms of the Uterus |
https://ClinicalTrials.gov/show/NCT02744898 |
Active, not recruiting |
NYU Langone Health |
2018-08-17 |
| NCT02730923 |
Hormone Receptor Positive endometrIal Carcinoma Treated by Dual mTORC1/mTORC2 Inhibitor and Anastrozole (VICTORIA) |
https://ClinicalTrials.gov/show/NCT02730923 |
Recruiting |
Centre Leon Berard |
2019-11-30 |
| NCT02730429 |
Trial of Letrozole + Palbociclib/Placebo in Metastatic Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT02730429 |
Active, not recruiting |
Nordic Society of Gynaecological Oncology - Clinical Trials Unit |
2018-12-15 |
| NCT02730416 |
Combination Chemotherapy With Nintedanib / Placebo in Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT02730416 |
Active, not recruiting |
Nordic Society of Gynaecological Oncology - Clinical Trials Unit |
2019-03-31 |
| NCT02728830 |
A Study of Pembrolizumab on the Tumoral Immunoprofile of Gynecologic Cancers |
https://ClinicalTrials.gov/show/NCT02728830 |
Active, not recruiting |
Duke University |
2019-01-31 |
| NCT02725489 |
Pilot Study of Durvalumab and Vigil in Advanced Women’s Cancers |
https://ClinicalTrials.gov/show/NCT02725489 |
Active, not recruiting |
Mary Crowley Medical Research Center |
2019-12-30 |
| NCT02725268 |
A Study of Sapanisertib, Combination of Sapanisertib With MLN1117, Paclitaxel and Combination of Sapanisertib With Paclitaxel in Women With Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT02725268 |
Active, not recruiting |
Takeda |
2019-07-02 |
| NCT02714621 |
MR-HIFU for Recurrent Gynaecological Cancer |
https://ClinicalTrials.gov/show/NCT02714621 |
Recruiting |
Institute of Cancer Research, United Kingdom |
2020-03-31 |
| NCT02690766 |
Translating Healthy Lifestyle Interventions for Cancer Survivors |
https://ClinicalTrials.gov/show/NCT02690766 |
Completed |
University of North Carolina, Chapel Hill |
2016-05-31 |
| NCT02684227 |
Enzalutamide, Carboplatin, and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrioid Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT02684227 |
Recruiting |
M.D. Anderson Cancer Center |
2020-12-31 |
| NCT02676726 |
STELLA 2 Trial: Transperitoneal vs. Extraperitoneal Approach for Laparoscopic Staging of Endometrial/Ovarian Cancer |
https://ClinicalTrials.gov/show/NCT02676726 |
Completed |
Hospital Universitari Vall d’Hebron Research Institute |
2019-09-30 |
| NCT02658565 |
Selective Surgical Staging for the Treatment of Endometrial Cancer Based on Intraoperative Consultation |
https://ClinicalTrials.gov/show/NCT02658565 |
Recruiting |
University of Kentucky |
2020-12-31 |
| NCT02657928 |
Ribociclib and Letrozole in Treating Patients With Relapsed ER Positive Ovarian, Fallopian Tube, Primary Peritoneal, or Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT02657928 |
Active, not recruiting |
Mayo Clinic |
2018-05-21 |
| NCT02646748 |
Pembrolizumab Combined With Itacitinib (INCB039110) and/or Pembrolizumab Combined With INCB050465 in Advanced Solid Tumors |
https://ClinicalTrials.gov/show/NCT02646748 |
Active, not recruiting |
Incyte Corporation |
2019-11-07 |
| NCT02646319 |
Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR Mutations |
https://ClinicalTrials.gov/show/NCT02646319 |
Completed |
Mayo Clinic |
2017-09-05 |
| NCT02630823 |
MK-3475 Immunotherapy in Endometrial Carcinoma |
https://ClinicalTrials.gov/show/NCT02630823 |
Active, not recruiting |
Washington University School of Medicine |
2019-01-01 |
| NCT02622776 |
Advanced Methods for Cancer Detection by Vaginal Screening |
https://ClinicalTrials.gov/show/NCT02622776 |
Completed |
British Columbia Cancer Agency |
2018-08-31 |
| NCT02611024 |
Pharmacokinetic Study of PM01183 in Combination With Irinotecan in Patients With Selected Solid Tumors |
https://ClinicalTrials.gov/show/NCT02611024 |
Recruiting |
PharmaMar |
2020-11-30 |
| NCT02598219 |
Evaluation of Sentinel Node Policy in Early Stage Endometrial Carcinomas at Intermediate and High Risk of Recurrence. |
https://ClinicalTrials.gov/show/NCT02598219 |
Active, not recruiting |
Centre Oscar Lambret |
2021-11-30 |
| NCT02584478 |
Phase 1/2a Evaluation of Adding AL3818 to Standard Platinum-Based Chemotherapy in Subjects With Recurrent or Metastatic Endometrial, Ovarian, Fallopian, Primary Peritoneal or Cervical Carcinoma (AL3818-US-002) |
https://ClinicalTrials.gov/show/NCT02584478 |
Recruiting |
Advenchen Laboratories, LLC |
2020-12-31 |
| NCT01977274 |
Predictive Clinical and Biological Parameters in Gynecological Cancer |
https://ClinicalTrials.gov/show/NCT01977274 |
Recruiting |
Institut Paoli-Calmettes |
2023-12-31 |
| NCT02575872 |
Physical Activity Behavioral Intervention in Obese Endometrial Cancer Survivors |
https://ClinicalTrials.gov/show/NCT02575872 |
Completed |
Albert Einstein College of Medicine |
2018-04-30 |
| NCT02767362 |
A Pre-Op Window Study Evaluating Anti-Proliferative Effects of Atorvastatin on the Endometrium |
https://ClinicalTrials.gov/show/NCT02767362 |
Completed |
UNC Lineberger Comprehensive Cancer Center |
2019-09-26 |
| NCT02632448 |
A Study of LY2880070 in Participants With Advanced or Metastatic Cancer |
https://ClinicalTrials.gov/show/NCT02632448 |
Recruiting |
Esperas Pharma Inc. |
2020-03-27 |
| NCT02465060 |
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) |
https://ClinicalTrials.gov/show/NCT02465060 |
Recruiting |
National Cancer Institute (NCI) |
2022-06-30 |
| NCT02269293 |
Selective Inhibitor of Nuclear Export, Selinexor (KPT-330) in Combination With Paclitaxel and Carboplatin in Patients With Advanced Ovarian or Endometrial Cancers |
https://ClinicalTrials.gov/show/NCT02269293 |
Recruiting |
Memorial Sloan Kettering Cancer Center |
2021-10-31 |
| NCT02564276 |
Indocyanine Green Versus Blue Dye for Detection of Sentinel Lymph Node In Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT02564276 |
Completed |
Centre hospitalier de l’Université de Montréal (CHUM) |
2017-04-30 |
| NCT02560571 |
Pre-operative Studies for Prediction of Lymph Nodes Involvement in Endometrial Cancer Patients |
https://ClinicalTrials.gov/show/NCT02560571 |
Recruiting |
Meir Medical Center |
2020-10-31 |
| NCT02552121 |
Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid Tumors |
https://ClinicalTrials.gov/show/NCT02552121 |
Completed |
Genmab |
2017-12-13 |
| NCT02549989 |
Study of LY3023414 for the Treatment of Recurrent or Persistent Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT02549989 |
Active, not recruiting |
Memorial Sloan Kettering Cancer Center |
2021-09-30 |
| NCT02549209 |
Pembro/Carbo/Taxol in Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT02549209 |
Recruiting |
Big Ten Cancer Research Consortium |
2019-12-01 |
| NCT02543710 |
Biomarker Guided Treatment in Gynaecological Cancer |
https://ClinicalTrials.gov/show/NCT02543710 |
Recruiting |
Haukeland University Hospital |
2020-12-31 |
| NCT02494791 |
Universal Screening for Lynch Syndrome in Women With Endometrial and Non-Serous Ovarian Cancer |
https://ClinicalTrials.gov/show/NCT02494791 |
Active, not recruiting |
University Health Network, Toronto |
2020-07-31 |
| NCT02476955 |
Open-label Phase 1b Study of ARQ 092 in Combination With Anastrozole |
https://ClinicalTrials.gov/show/NCT02476955 |
Active, not recruiting |
ArQule |
2020-12-31 |
| NCT02433626 |
Study of COTI-2 as Monotherapy or Combination Therapy for the Treatment of Malignancies |
https://ClinicalTrials.gov/show/NCT02433626 |
Recruiting |
Critical Outcome Technologies Inc. |
2019-12-31 |
| NCT02433080 |
Diet and Physical Activity in Uterine Cancer Survivors |
https://ClinicalTrials.gov/show/NCT02433080 |
Completed |
University College, London |
2015-12-31 |
| NCT02431676 |
Survivorship Promotion In Reducing IGF-1 Trial |
https://ClinicalTrials.gov/show/NCT02431676 |
Completed |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2018-12-31 |
| NCT02413606 |
ENdometrial Cancer SURvivors’ Follow-up carE (ENSURE): Less is More? |
https://ClinicalTrials.gov/show/NCT02413606 |
Recruiting |
Comprehensive Cancer Centre The Netherlands |
2021-03-31 |
| NCT02397083 |
Levonorgestrel-Releasing Intrauterine System With or Without Everolimus in Treating Patients With Atypical Hyperplasia or Stage IA Grade 1 Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT02397083 |
Recruiting |
M.D. Anderson Cancer Center |
2026-09-30 |
| NCT02393248 |
Open-Label, Dose-Escalation Study of Pemigatinib in Subjects With Advanced Malignancies - (FIGHT-101) |
https://ClinicalTrials.gov/show/NCT02393248 |
Recruiting |
Incyte Corporation |
2020-07-31 |
| NCT02387645 |
LUDEC Study - Pilot Study of the Lavage of the Uterine Cavity for the Diagnosis of Endometrial Carcinoma |
https://ClinicalTrials.gov/show/NCT02387645 |
Completed |
Medical University of Vienna |
2017-05-31 |
| NCT02351479 |
Hula, a Physical Activity Intervention for Female-Cancer Survivors |
https://ClinicalTrials.gov/show/NCT02351479 |
Completed |
University of Hawaii |
2017-12-31 |
| NCT02342730 |
Weight Loss Referral for Healthier Survivorship in Obese Stage I-II Endometrial Cancer Survivors or Atypical Hyperplasia |
https://ClinicalTrials.gov/show/NCT02342730 |
Completed |
Case Comprehensive Cancer Center |
2015-05-18 |
| NCT02320565 |
2D Versus 3D Radical Laparoscopic Hysterectomy for Endometrial Cancer: a Prospective Randomized Trial |
https://ClinicalTrials.gov/show/NCT02320565 |
Completed |
Catholic University of the Sacred Heart |
2015-03-31 |
| NCT02285192 |
Positron Lymphography Via Intracervical 18F-FDG Injection for Pre-surgical Lymphatic Mapping in Stage IB1 Cervical Cancer and High-grade Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT02285192 |
Recruiting |
Memorial Sloan Kettering Cancer Center |
2020-11-30 |
| NCT02262455 |
Effects of STM 434 Alone or in Combination With Liposomal Doxorubicin in Patients With Ovarian Cancer or Other Advanced Solid Tumors |
https://ClinicalTrials.gov/show/NCT02262455 |
Completed |
Santa Maria Biotherapeutics |
2017-01-13 |
| NCT02228681 |
Everolimus and Letrozole or Hormonal Therapy to Treat Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT02228681 |
Active, not recruiting |
Gynecologic Oncology Group |
2018-01-31 |
| NCT02221076 |
Probe-based and Needle-based Confocal Laser Endomicroscopy During Gynaecological Procedures. |
https://ClinicalTrials.gov/show/NCT02221076 |
Completed |
Mauna Kea Technologies |
2016-04-18 |
| NCT02209532 |
A Study Assessing the Safety and Utility of PINPOINT® Near Infrared Fluorescence Imaging in the Identification of Lymph Nodes in Patients With Uterine and Cervical Malignancies Who Are Undergoing Lymph Node Mapping |
https://ClinicalTrials.gov/show/NCT02209532 |
Completed |
Novadaq Technologies ULC, now a part of Stryker |
2017-06-30 |
| NCT02178722 |
Study to Explore the Safety, Tolerability and Efficacy of MK-3475 in Combination With INCB024360 in Participants With Selected Cancers |
https://ClinicalTrials.gov/show/NCT02178722 |
Active, not recruiting |
Incyte Corporation |
2018-11-26 |
| NCT02135562 |
Protein-Sparing Modified Fast Intervention for Weight Loss in Obese Endometrial Cancer Survivors |
https://ClinicalTrials.gov/show/NCT02135562 |
Completed |
Case Comprehensive Cancer Center |
2017-04-19 |
| NCT02096783 |
Scripted Sexual Health Informational Intervention in Improving Sexual Function in Patients With Gynecologic Cancer |
https://ClinicalTrials.gov/show/NCT02096783 |
Completed |
University of Wisconsin, Madison |
2015-06-30 |
| NCT02093598 |
POEM STUDY: A Phase IIa Trial in Endometrial Carcinoma With Temsirolimus |
https://ClinicalTrials.gov/show/NCT02093598 |
Completed |
MedSIR |
2014-03-31 |
| NCT02091050 |
2D vs 3D Planning for High-Dose Rate (HDR) Gynecological Brachytherapy |
https://ClinicalTrials.gov/show/NCT02091050 |
Completed |
AC Camargo Cancer Center |
2015-03-31 |
| NCT02069158 |
Dose Finding Study Of PF-05212384 With Paclitaxel And Carboplatin In Patients With Advanced Solid Tumor |
https://ClinicalTrials.gov/show/NCT02069158 |
Completed |
Oncology Institute of Southern Switzerland |
2019-05-31 |
| NCT02068820 |
Detection of SLN in Patients With Endometrial Cancer Undergoing Robotic Assisted Staging: Comparison of ISB and ICG |
https://ClinicalTrials.gov/show/NCT02068820 |
Completed |
AdventHealth |
2015-01-31 |
| NCT02065687 |
Paclitaxel and Carboplatin With or Without Metformin Hydrochloride in Treating Patients With Stage III, IV, or Recurrent Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT02065687 |
Active, not recruiting |
Gynecologic Oncology Group |
2019-09-01 |
| NCT02058550 |
Phone or Email Reminder in Increasing Vaginal Dilator Use in Patients With Gynecologic Cancers Undergoing Brachytherapy |
https://ClinicalTrials.gov/show/NCT02058550 |
Active, not recruiting |
Stanford University |
2019-01-31 |
| NCT01307631 |
Akt Inhibitor MK2206 in Treating Patients With Recurrent or Advanced Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT01307631 |
Completed |
National Cancer Institute (NCI) |
2016-01-31 |
| NCT01289041 |
BKM120 as Second-line Therapy for Advanced Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT01289041 |
Completed |
Novartis |
2014-03-31 |
| NCT01271764 |
The Association of G9a Protein and Outcome of Patients With Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT01271764 |
Completed |
Far Eastern Memorial Hospital |
2012-07-31 |
| NCT02040155 |
Real Time In-Vivo Dosimetry For Gynecologic Brachytherapy |
https://ClinicalTrials.gov/show/NCT02040155 |
Completed |
Duke University |
2015-08-31 |
| NCT04453904 |
Modality of Adjuvant Radiotherapy and Chemotherapy for Stage â…¢ Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT04453904 |
Recruiting |
Peking University People’s Hospital |
2025-04-30 |
| NCT03603184 |
Atezolizumab Trial in Endometrial Cancer - AtTEnd |
https://ClinicalTrials.gov/show/NCT03603184 |
Recruiting |
Mario Negri Institute for Pharmacological Research |
2021-07-31 |
| NCT03526432 |
Phase II Study of Atezolizumab + Bevacizumab in Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT03526432 |
Recruiting |
University of Oklahoma |
2021-05-25 |
| NCT02017353 |
Effect of Curcumin Addition to Standard Treatment on Tumour-induced Inflammation in Endometrial Carcinoma |
https://ClinicalTrials.gov/show/NCT02017353 |
Completed |
University Hospital, Gasthuisberg |
2016-05-31 |
| NCT02001623 |
Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid Tumors |
https://ClinicalTrials.gov/show/NCT02001623 |
Completed |
Genmab |
2019-05-02 |
| NCT02025985 |
Phase II Study of KPT-330 (Selinexor) in Female Patients With Advanced Gynaecologic Malignancies & Metastatic Breast Cancer |
https://ClinicalTrials.gov/show/NCT02025985 |
Completed |
Karyopharm Therapeutics Inc |
2017-02-13 |
| NCT01979003 |
A Pilot Study to Determine the Efficacy of Fluorescein Visualization of the Uterus in Detecting Endometrial Cancer Invasion |
https://ClinicalTrials.gov/show/NCT01979003 |
Active, not recruiting |
University of Arkansas |
2020-10-31 |
| NCT01965080 |
Exemestane in Advanced and Recurrent Endometrial Carcinoma |
https://ClinicalTrials.gov/show/NCT01965080 |
Completed |
Nordic Society of Gynaecological Oncology - Clinical Trials Unit |
2009-02-28 |
| NCT01935973 |
Trametinib With or Without GSK2141795 in Treating Patients With Recurrent or Persistent Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT01935973 |
Active, not recruiting |
National Cancer Institute (NCI) |
2017-02-01 |
| NCT01935934 |
Cabozantinib S-Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT01935934 |
Active, not recruiting |
National Cancer Institute (NCI) |
2019-09-12 |
| NCT01922778 |
Screening for Endometrial Abnormalities in Overweight and Obese Women |
https://ClinicalTrials.gov/show/NCT01922778 |
Completed |
St. Luke’s-Roosevelt Hospital Center |
2016-03-31 |
| NCT01911247 |
Preoperative Window Study of Metformin for the Treatment of Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT01911247 |
Completed |
UNC Lineberger Comprehensive Cancer Center |
2013-02-28 |
| NCT01908504 |
Adaptive Pet Study |
https://ClinicalTrials.gov/show/NCT01908504 |
Completed |
Duke University |
2016-09-30 |
| NCT01886066 |
Accuracy of Sentinel Lymph Node Biopsy in Nodal Staging of High Risk Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT01886066 |
Active, not recruiting |
University Health Network, Toronto |
2020-05-31 |
| NCT01870947 |
Assisted Exercise in Obese Endometrial Cancer Patients |
https://ClinicalTrials.gov/show/NCT01870947 |
Completed |
Case Comprehensive Cancer Center |
2019-09-04 |
| NCT01847703 |
Robotic Versus Abdominal Surgery for Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT01847703 |
Completed |
Karolinska Institutet |
2016-07-31 |
| NCT01820884 |
The Safety of Ovarian Preservation in Stage IA Endometrial Carcinoma |
https://ClinicalTrials.gov/show/NCT01820884 |
Recruiting |
Huazhong University of Science and Technology |
2020-12-31 |
| NCT01820858 |
The Efficacy and Safety of the Postoperative Adjuvant Treatment in Patients With High-risk Stage I Endometrial Carcinoma |
https://ClinicalTrials.gov/show/NCT01820858 |
Recruiting |
Huazhong University of Science and Technology |
2019-04-30 |
| NCT01818739 |
Lymph Node Mapping in Patients With Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT01818739 |
Completed |
Ohio State University Comprehensive Cancer Center |
2016-11-16 |
| NCT01810874 |
STELLA Trial: Transperitoneal vs. Extraperitoneal Approach for Laparoscopic Staging of Endometrial/Ovarian Cancer |
https://ClinicalTrials.gov/show/NCT01810874 |
Completed |
Hospital Universitari Vall d’Hebron Research Institute |
2014-07-31 |
| NCT01797523 |
A Phase II, Single-Arm Study of RAD001 (Everolimus), Letrozole, and Metformin in Patients With Advanced or Recurrent Endometrial Carcinoma |
https://ClinicalTrials.gov/show/NCT01797523 |
Active, not recruiting |
M.D. Anderson Cancer Center |
2020-10-31 |
| NCT01767155 |
Zoptarelin Doxorubicin (AEZS 108) as Second Line Therapy for Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT01767155 |
Completed |
AEterna Zentaris |
2017-01-30 |
| NCT01764802 |
Psychosexual Intervention in Patients With Stage I-III Gynecologic or Breast Cancer |
https://ClinicalTrials.gov/show/NCT01764802 |
Completed |
Ohio State University Comprehensive Cancer Center |
2017-06-01 |
| NCT01764789 |
Stress Reduction in Improving Quality of Life in Patients With Recurrent Gynecologic or Breast Cancer |
https://ClinicalTrials.gov/show/NCT01764789 |
Completed |
Ohio State University Comprehensive Cancer Center |
2012-01-31 |
| NCT01738152 |
Non-Hormonal Vaginal Moisturizer in Hormone-Receptor Positive Postmenopausal Cancer Survivors Experiencing Estrogen Deprivation Symptoms on Vulvovaginal Health |
https://ClinicalTrials.gov/show/NCT01738152 |
Active, not recruiting |
Memorial Sloan Kettering Cancer Center |
2020-11-30 |
| NCT01737619 |
PET/CT and Lymph Node Mapping in Finding Lymph Node Metastasis in Patients With High-Risk Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT01737619 |
Active, not recruiting |
M.D. Anderson Cancer Center |
2020-04-30 |
| NCT01717391 |
[F-18] Fluorothymidine PET/CT Imaging for Pelvic Cancers |
https://ClinicalTrials.gov/show/NCT01717391 |
Completed |
University of Iowa |
2016-02-29 |
| NCT01705288 |
Implementation of a Rapid Recovery Program in Gynecologic Oncology Surgery: A Pilot Study |
https://ClinicalTrials.gov/show/NCT01705288 |
Completed |
Masonic Cancer Center, University of Minnesota |
2016-08-24 |
| NCT01697566 |
An Endometrial Cancer Chemoprevention Study of Metformin |
https://ClinicalTrials.gov/show/NCT01697566 |
Active, not recruiting |
M.D. Anderson Cancer Center |
2021-09-30 |
| NCT01689714 |
Safety and Efficacy of Folatescan (Technetium TC 99M EC20) in Patients With Suspected Ovarian Carcinoma or Recurrent Endometrial Carcinoma |
https://ClinicalTrials.gov/show/NCT01689714 |
Completed |
Endocyte |
NA |
| NCT01686256 |
Safety and Efficacy of FolateScan (Technetium Tc 99m EC20) in Women With Suspected Ovarian or Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT01686256 |
Completed |
Endocyte |
2004-08-31 |
| NCT01673022 |
Determining the Sensitivity of Sentinel Lymph Nodes Identified With Robotic Fluorescence Imaging |
https://ClinicalTrials.gov/show/NCT01673022 |
Completed |
Indiana University |
2017-01-31 |
| NCT01652794 |
Carboplatin, Gemcitabine Hydrochloride, and Stereotactic Body Radiation Therapy in Gynecological Cancer |
https://ClinicalTrials.gov/show/NCT01652794 |
Completed |
Case Comprehensive Cancer Center |
2014-05-31 |
| NCT03349463 |
Evaluation of Fluciclovine Uptake in Patients With Cervical, Ovarian Epithelial or Endometrial Cancers. |
https://ClinicalTrials.gov/show/NCT03349463 |
Recruiting |
Loyola University |
2020-12-31 |
| NCT01631552 |
Phase I/II Study of IMMU-132 in Patients With Epithelial Cancers |
https://ClinicalTrials.gov/show/NCT01631552 |
Active, not recruiting |
Immunomedics, Inc. |
2020-06-30 |
| NCT01610375 |
Telephone Follow-up After Treatment for Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT01610375 |
Completed |
Queensland Centre for Gynaecological Cancer |
2014-03-31 |
| NCT01588522 |
Compound 31543 (Calcitriol, USP) in Patients Receiving Taxane-based Chemotherapy Regimens for Advanced or Recurrent Disease |
https://ClinicalTrials.gov/show/NCT01588522 |
Completed |
Berg, LLC |
2017-01-31 |
| NCT01580696 |
Phase I/IIa Trial of Folate Binding Protein Vaccine in Ovarian Cancer |
https://ClinicalTrials.gov/show/NCT01580696 |
Completed |
San Antonio Military Medical Center |
2016-07-31 |
| NCT01562106 |
Investigating the Use of Fluorescence Imaging in Endometrial Cancer Surgery |
https://ClinicalTrials.gov/show/NCT01562106 |
Completed |
Swedish Medical Center |
2015-09-30 |
| NCT01549782 |
Mixture of Prebiotics on Intestinal Microbiota of Patients Receiving Abdominal Radiotherapy. |
https://ClinicalTrials.gov/show/NCT01549782 |
Completed |
Hospital General Universitario Gregorio Marañon |
2007-12-31 |
| NCT01526655 |
Robot Assisted Laparoscopic Hysterectomy vs. Abdominal Hysterectomy in Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT01526655 |
Completed |
University Hospital, Linkoeping |
2016-07-27 |
| NCT01523678 |
Weekly Paclitaxel/Carboplatin With Neupogen in Gynaecological Cancers |
https://ClinicalTrials.gov/show/NCT01523678 |
Completed |
Belgian Gynaecological Oncology Group |
2014-05-31 |
| NCT01512810 |
Intraoperative Pathological Evaluation for Surgical Treatment & Staging for Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT01512810 |
Active, not recruiting |
University of Kentucky |
2020-07-28 |
| NCT01482728 |
Bristol-Myers Squibb Dasatinib Src Inhibition in Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT01482728 |
Completed |
University of Virginia |
2015-05-31 |
| NCT01470677 |
Tachosil for the Prevention of Symptomatic Lymph Cysts |
https://ClinicalTrials.gov/show/NCT01470677 |
Completed |
Ruhr University of Bochum |
2016-01-31 |
| NCT01467219 |
Pilot Study Using a PET Gamma Probe to Evaluate Lymph Nodes in Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT01467219 |
Completed |
University Health Network, Toronto |
2014-03-31 |
| NCT01466777 |
Endometrial Cancer and Robotic-assisted Versus Traditional Laparoscopy |
https://ClinicalTrials.gov/show/NCT01466777 |
Active, not recruiting |
Tampere University Hospital |
2019-08-31 |
| NCT01460979 |
Efficacy,Tolerability,Safety of Temsirolimus in Women With Platinum-refractory Ovarian Carcinoma or Advanced Endometrial Carcinoma |
https://ClinicalTrials.gov/show/NCT01460979 |
Completed |
AGO Study Group |
2015-06-30 |
| NCT01455493 |
A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma |
https://ClinicalTrials.gov/show/NCT01455493 |
Completed |
Genentech, Inc. |
2013-03-31 |
| NCT01440998 |
Dasatinib, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT01440998 |
Completed |
National Cancer Institute (NCI) |
2015-12-31 |
| NCT01397877 |
GINECO-EN102b - BKM120 as Monotherapy in the Treatment of Initial or Recurrent Metastatic Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT01397877 |
Completed |
ARCAGY/ GINECO GROUP |
2014-10-31 |
| NCT01379534 |
A Phase II Study to Evaluate the Efficacy of TKI258 for the Treatment of Patients With FGFR2 Mutated or Wild-type Advanced and/or Metastatic Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT01379534 |
Completed |
Novartis |
2014-03-31 |
| NCT01367002 |
Evaluation of Carboplatin/Paclitaxel With and Without Trastuzumab (Herceptin) in Uterine Serous Cancer |
https://ClinicalTrials.gov/show/NCT01367002 |
Active, not recruiting |
Yale University |
2020-12-31 |
| NCT01366144 |
Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction |
https://ClinicalTrials.gov/show/NCT01366144 |
Active, not recruiting |
National Cancer Institute (NCI) |
2017-11-10 |
| NCT01364844 |
Safety and Tolerability of DS-7423 in Subjects With Advanced Solid Malignant Tumors |
https://ClinicalTrials.gov/show/NCT01364844 |
Completed |
Daiichi Sankyo, Inc. |
2013-11-30 |
| NCT04438564 |
Immunoassay and Regulation of Traditional Chinese Medicine on Cancer Patients |
https://ClinicalTrials.gov/show/NCT04438564 |
Recruiting |
China Medical University Hospital |
2021-12-31 |
| NCT04295109 |
Comparison of the Effects of Fentanyl, Oxycodone, Butorphanol on Gastrointestinal Function |
https://ClinicalTrials.gov/show/NCT04295109 |
Recruiting |
The First Affiliated Hospital with Nanjing Medical University |
2020-07-31 |
| NCT04291105 |
Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients |
https://ClinicalTrials.gov/show/NCT04291105 |
Recruiting |
Vyriad, Inc. |
2022-03-31 |
| NCT04276532 |
Sentinel Lymph Node Sampling for Patients With Middle-high Risk Endometrial Cancer Confined to the Uterus |
https://ClinicalTrials.gov/show/NCT04276532 |
Recruiting |
Fudan University |
2025-01-10 |
| NCT04302714 |
Hysteroscopic vs. Cervical Injection for Sentinel Node Detection of Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT04302714 |
Completed |
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano |
2019-03-28 |
| NCT04269200 |
Durvalumab With or Without Olaparib as Maintenance Therapy After First-Line Treatment of Advanced and Recurrent Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT04269200 |
Recruiting |
AstraZeneca |
2023-06-05 |
| NCT04251416 |
A Study of Sacituzumab Govitecan (IMMU-132) in Endometrial Carcinoma |
https://ClinicalTrials.gov/show/NCT04251416 |
Recruiting |
Yale University |
2024-02-29 |
| NCT04235179 |
Adjuvant Stereotactic Pelvic Irradiation in Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT04235179 |
Recruiting |
King Saud University |
2022-01-31 |
| NCT04224467 |
The Application of Real-Time Near-infrared Imaging in Gynecological Surgery |
https://ClinicalTrials.gov/show/NCT04224467 |
Recruiting |
Southern Medical University, China |
2024-11-30 |
| NCT04212377 |
Dendritic Cells for Immunotherapy of Metastatic Endometrial Cancer Patients |
https://ClinicalTrials.gov/show/NCT04212377 |
Recruiting |
Radboud University |
2022-02-28 |
| NCT04188548 |
A Study of LY3484356 in Participants With Advanced or Metastatic Breast Cancer or Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT04188548 |
Recruiting |
Eli Lilly and Company |
2022-10-28 |
| NCT04157491 |
Anti-PD-1 Antibody Combined With Anlotinib in the Treatment of Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT04157491 |
Recruiting |
Sun Yat-sen University |
2020-12-31 |
| NCT04152018 |
Study of PF‑06940434 in Patients With Advanced or Metastatic Solid Tumors. |
https://ClinicalTrials.gov/show/NCT04152018 |
Recruiting |
Pfizer |
2024-03-02 |
| NCT04149691 |
Safety, Tolerability and Pharmacokinetics of Oral CPL304110, in Adult Subjects With Advanced Solid Malignancies |
https://ClinicalTrials.gov/show/NCT04149691 |
Recruiting |
Celon Pharma SA |
2020-07-31 |
| NCT04122235 |
The Lifestyle and Empowerment Techniques in Survivorship of Gynecologic Oncology Study |
https://ClinicalTrials.gov/show/NCT04122235 |
Recruiting |
Sorlandet Hospital HF |
2024-12-31 |
| NCT04106414 |
Study of BMS-986205 and Nivolumab in Endometrial Cancer or Endometrial Carcinosarcoma That Has Not Responded to Treatment |
https://ClinicalTrials.gov/show/NCT04106414 |
Recruiting |
Memorial Sloan Kettering Cancer Center |
2021-09-30 |
| NCT04080284 |
Trial of Maintenance With Niraparib- Uterine Serous Carcinoma |
https://ClinicalTrials.gov/show/NCT04080284 |
Recruiting |
Northwell Health |
2022-07-01 |
| NCT04068675 |
Effects of Centering Pre-operative Counseling on Patient Reported Anxiety |
https://ClinicalTrials.gov/show/NCT04068675 |
Recruiting |
Northwestern University |
2020-06-30 |
| NCT04025229 |
High Intensity Interval Training in Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT04025229 |
Active, not recruiting |
UNC Lineberger Comprehensive Cancer Center |
2021-05-20 |
| NCT04021459 |
Research of Circulating Tumor Cells Released During Endometrial Cancer Surgery. |
https://ClinicalTrials.gov/show/NCT04021459 |
Recruiting |
University Hospital, Montpellier |
2020-09-02 |
| NCT04014530 |
Pembrolizumab With Ataluren in Patients With Metastatic pMMR and dMMR Colorectal Carcinoma or Metastatic dMMR Endometrial Carcinoma: the ATAPEMBRO Study |
https://ClinicalTrials.gov/show/NCT04014530 |
Recruiting |
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) |
2021-08-01 |
| NCT03983954 |
Naptumomab Estafenatox in Combination With Durvalumab in Subjects With Selected Advanced or Metastatic Solid Tumors |
https://ClinicalTrials.gov/show/NCT03983954 |
Recruiting |
NeoTX Therapeutics Ltd. |
2021-11-01 |
| NCT03968406 |
Talazoparib and Radiation Therapy in Treating Patients With Locally Recurrent Gynecologic Cancers |
https://ClinicalTrials.gov/show/NCT03968406 |
Recruiting |
M.D. Anderson Cancer Center |
2021-10-11 |
| NCT03955978 |
TSR-042 in Addition to Standard of Care Definitive Radiation for Inoperable Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT03955978 |
Recruiting |
Washington University School of Medicine |
2022-03-31 |
| NCT03951415 |
Durvalumab and Olaparib in Metastatic or Recurrent Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT03951415 |
Recruiting |
Leiden University Medical Center |
2023-07-01 |
| NCT03935282 |
Assessing Effectiveness and Implementation of an EHR Tool to Assess Heart Health Among Survivors |
https://ClinicalTrials.gov/show/NCT03935282 |
Enrolling by invitation |
Wake Forest University Health Sciences |
2023-05-31 |
| NCT03935256 |
Adjuvant Sequential & Concurrent CarboTaxol + Radiotherapy for High Risk Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT03935256 |
Recruiting |
Loyola University |
2021-03-31 |
| NCT03924245 |
Olaparib and Entinostat in Patients With Recurrent, Platinum-Refractory, Resistant Ovarian, Primary Peritoneal, Fallopian Tube Cancers |
https://ClinicalTrials.gov/show/NCT03924245 |
Recruiting |
Vanderbilt-Ingram Cancer Center |
2023-09-30 |
| NCT03917381 |
GEN1046 Safety Trial in Patients With Malignant Solid Tumors |
https://ClinicalTrials.gov/show/NCT03917381 |
Recruiting |
Genmab |
2021-10-31 |
| NCT03909152 |
A Study of Onapristone ER in Low Grade Serous Ovarian Cancer and Other Progesterone Receptor Positive Gynecologic Cancers |
https://ClinicalTrials.gov/show/NCT03909152 |
Recruiting |
Memorial Sloan Kettering Cancer Center |
2021-04-30 |
| NCT03908996 |
the Effectiveness of a Weight Management Program in Patients Who Have Completed Treatment for Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT03908996 |
Recruiting |
Sanford Health |
2020-04-15 |
| NCT03900104 |
Cervical and Endometrial Injection for Sentinel Lymph Node Detection in Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT03900104 |
Completed |
Kocaeli University |
2020-01-01 |
| NCT03899441 |
Multimedia Aid Gynecologic Counseling and Consent |
https://ClinicalTrials.gov/show/NCT03899441 |
Recruiting |
UNC Lineberger Comprehensive Cancer Center |
2020-04-01 |
| NCT03896113 |
Neoadjuvant Celecoxib in Newly Diagnosed Patients With Endometrial Carcinoma |
https://ClinicalTrials.gov/show/NCT03896113 |
Recruiting |
Cliniques universitaires Saint-Luc- Université Catholique de Louvain |
2022-06-30 |
| NCT03876860 |
An Enhanced Vaginal Dilator to Reduce Radiation-Induced Vaginal Stenosis |
https://ClinicalTrials.gov/show/NCT03876860 |
Recruiting |
Loyola University |
2021-04-01 |
| NCT03827837 |
Famitinib Plus Anti-PD1 Therapy for Advanced Urinary System Tumor, Advanced Gynecological Tumors |
https://ClinicalTrials.gov/show/NCT03827837 |
Recruiting |
Jiangsu HengRui Medicine Co., Ltd. |
2020-06-30 |
| NCT03787056 |
Predictive Value of Progastrin Titer at Diagnosis and of Progastrin Kinetics During Treatment in Cancer Patients |
https://ClinicalTrials.gov/show/NCT03787056 |
Recruiting |
Hospices Civils de Lyon |
2026-11-30 |
| NCT03785288 |
Vaginal Cuff Brachytherapy Fractionation Study |
https://ClinicalTrials.gov/show/NCT03785288 |
Recruiting |
University of Virginia |
2022-01-01 |
| NCT03778255 |
Sentinel Lymph Node Mapping In Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT03778255 |
Recruiting |
Peking University People’s Hospital |
2020-06-30 |
| NCT03776630 |
Exploring the Potential of Novel Biomarkers Based on Plasma microRNAs for a Better Management of Pelvic Gynecologic Tumors |
https://ClinicalTrials.gov/show/NCT03776630 |
Recruiting |
Assistance Publique - Hôpitaux de Paris |
2022-05-31 |
| NCT03752606 |
Application of Tachosil During Lymphadenectomy |
https://ClinicalTrials.gov/show/NCT03752606 |
Completed |
Medical University of Lublin |
2014-12-31 |
| NCT03752398 |
A Study of XmAb®23104 in Subjects With Selected Advanced Solid Tumors (DUET-3) |
https://ClinicalTrials.gov/show/NCT03752398 |
Recruiting |
Xencor, Inc. |
2024-09-30 |
| NCT03748186 |
Study of STRO-002, an Anti-Folate Receptor Alpha (FolRα) Antibody Drug Conjugate in Ovarian & Endometrial Cancers |
https://ClinicalTrials.gov/show/NCT03748186 |
Recruiting |
Sutro Biopharma, Inc. |
2022-08-31 |
| NCT03698604 |
Total Laparoscopic Hysterectomy Versus Total Abdominal Hysterectomy in Women With Endometrial Neoplasia |
https://ClinicalTrials.gov/show/NCT03698604 |
Completed |
Ain Shams Maternity Hospital |
2018-05-01 |
| NCT03694262 |
The EndoBARR Trial (Endometrial Bevacizumab, Atezolizumab, Rucaparib) |
https://ClinicalTrials.gov/show/NCT03694262 |
Recruiting |
Medical College of Wisconsin |
2021-06-28 |
| NCT03675893 |
Abemaciclib With Letrozole in Recurrent or Persistent Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT03675893 |
Recruiting |
Dana-Farber Cancer Institute |
2021-05-01 |
| NCT03671811 |
Megestrol Acetate With or Without Pterostilbene in Treating Patients With Endometrial Cancer Undergoing Hysterectomy |
https://ClinicalTrials.gov/show/NCT03671811 |
Recruiting |
City of Hope Medical Center |
2020-12-07 |
| NCT03667716 |
COM701 in Subjects With Advanced Solid Tumors |
https://ClinicalTrials.gov/show/NCT03667716 |
Recruiting |
Compugen Ltd |
2021-06-30 |
| NCT03653819 |
High Intensity Interval Training (HIIT) for Patients With Cancer-related Lymphedema in the Lower Limbs |
https://ClinicalTrials.gov/show/NCT03653819 |
Completed |
Herlev and Gentofte Hospital |
2018-11-13 |
| NCT03629756 |
A Study to Evaluate the Safety and Tolerability of Immunotherapy Combinations in Participants With Advanced Malignancies |
https://ClinicalTrials.gov/show/NCT03629756 |
Recruiting |
Arcus Biosciences, Inc. |
2021-01-31 |
| NCT03618472 |
Comparison of the Effectiveness Metformin for Deceasing Proliferative Marker in Endometrial Cancer Cells |
https://ClinicalTrials.gov/show/NCT03618472 |
Completed |
Rajavithi Hospital |
2019-11-30 |
| NCT03617679 |
Rucaparib vs Placebo Maintenance Therapy in Metastatic and Recurrent Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT03617679 |
Recruiting |
University of Colorado, Denver |
2021-09-30 |
| NCT03611517 |
Sexual Rehabilitation Programme After Radiotherapy for Gynaecological Cancer |
https://ClinicalTrials.gov/show/NCT03611517 |
Recruiting |
Leiden University Medical Center |
2022-07-31 |
| NCT03595722 |
Exploring HIFU as a Treatment for Rectal and Other Pelvic Cancers |
https://ClinicalTrials.gov/show/NCT03595722 |
Recruiting |
Imperial College London |
2022-08-28 |
| NCT03586661 |
Niraparib and Copanlisib in Treating Patients With Recurrent Endometrial, Ovarian, Primary Peritoneal, or Fallopian Tube Cancer |
https://ClinicalTrials.gov/show/NCT03586661 |
Recruiting |
M.D. Anderson Cancer Center |
2021-04-30 |
| NCT03580421 |
Cost-utility of Ambulatory Surgery in the Management of Endometrial Cancer(AMBU-ENDO) |
https://ClinicalTrials.gov/show/NCT03580421 |
Recruiting |
Assistance Publique - Hôpitaux de Paris |
2021-08-01 |
| NCT03572478 |
Rucaparib and Nivolumab in Patients With Prostate or Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT03572478 |
Active, not recruiting |
University of Chicago |
2020-02-29 |
| NCT03570437 |
Does Cediranib With Paclitaxel, or Cediranib and Olaparib, Treat Advanced Endometrial Cancer Better Than Paclitaxel? |
https://ClinicalTrials.gov/show/NCT03570437 |
Recruiting |
University of Manchester |
2021-01-31 |
| NCT03555422 |
Maintenance With Selinexor/Placebo After Combination Chemotherapy in Endometrial Cancer [SIENDO] |
https://ClinicalTrials.gov/show/NCT03555422 |
Recruiting |
Karyopharm Therapeutics Inc |
2023-03-31 |
| NCT03538704 |
Effect of Fertility-sparing Therapy of Early Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT03538704 |
Recruiting |
Peking University People’s Hospital |
2020-03-31 |
| NCT03538028 |
A Safety and Tolerability Study of INCAGN02385 in Select Advanced Malignancies |
https://ClinicalTrials.gov/show/NCT03538028 |
Recruiting |
Incyte Corporation |
2020-09-24 |
| NCT03517488 |
A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors |
https://ClinicalTrials.gov/show/NCT03517488 |
Recruiting |
Xencor, Inc. |
2020-12-31 |
| NCT03517449 |
Lenvatinib in Combination With Pembrolizumab Versus Treatment of Physician’s Choice in Participants With Advanced Endometrial Cancer (MK-3475-775/E7080-G000-309 Per Merck Standard Convention [KEYNOTE-775]) |
https://ClinicalTrials.gov/show/NCT03517449 |
Active, not recruiting |
Eisai Inc. |
2022-02-24 |
| NCT03514121 |
FPA150 in Patients With Advanced Solid Tumors |
https://ClinicalTrials.gov/show/NCT03514121 |
Active, not recruiting |
Five Prime Therapeutics, Inc. |
2023-01-31 |
| NCT03508570 |
Nivolumab With or Without Ipilimumab in Treating Patients With Recurrent or High Grade Gynecologic Cancer With Metastatic Peritoneal Carcinomatosis |
https://ClinicalTrials.gov/show/NCT03508570 |
Recruiting |
M.D. Anderson Cancer Center |
2021-01-01 |
| NCT03485729 |
ONC201 in Recurrent or Metastatic Type II Endometrial Cancer Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT03485729 |
Recruiting |
Oncoceutics, Inc. |
2020-03-21 |
| NCT03476798 |
Bevacizumab and Rucaparib in Recurrent Carcinoma of the Cervix or Endometrium |
https://ClinicalTrials.gov/show/NCT03476798 |
Active, not recruiting |
University of Oklahoma |
2020-05-12 |
| NCT03469674 |
PORTEC-4a: Molecular Profile-based Versus Standard Adjuvant Radiotherapy in Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT03469674 |
Recruiting |
Leiden University Medical Center |
2026-12-31 |
| NCT03466788 |
Impact of Adjuvant Chemotherapy on the Quality of Life of Patients Treated for Stage II / III Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT03466788 |
Completed |
Centre Francois Baclesse |
2019-03-28 |
| NCT03463252 |
Value of LNG-IUS as Fertility-preserving Treatment of EAH and EC |
https://ClinicalTrials.gov/show/NCT03463252 |
Recruiting |
West China Second University Hospital |
2019-12-30 |
| NCT03456908 |
F-18 TFB-PET Studies in Cancer Patients Undergoing NIS-containing Viral Therapies |
https://ClinicalTrials.gov/show/NCT03456908 |
Completed |
Mayo Clinic |
2019-12-31 |
| NCT03454451 |
CPI-006 Alone and in Combination With Ciforadenant and With Pembrolizumab for Patients With Advanced Cancers |
https://ClinicalTrials.gov/show/NCT03454451 |
Recruiting |
Corvus Pharmaceuticals, Inc. |
2022-03-31 |
| NCT03438474 |
Endometrial Cancer Lymphadenectomy Trial |
https://ClinicalTrials.gov/show/NCT03438474 |
Recruiting |
Philipps University Marburg Medical Center |
2028-02-15 |
| NCT03422198 |
Short Course Vaginal Cuff Brachytherapy in Treating Patients With Stage I-II Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT03422198 |
Recruiting |
University of Utah |
2022-01-08 |
| NCT01262040 |
Narrow Band Imaging (NBI): A Novel Imaging Modality in Minimally Invasive |
https://ClinicalTrials.gov/show/NCT01262040 |
Completed |
Memorial Sloan Kettering Cancer Center |
2018-10-29 |
| NCT01256268 |
Carboplatin/Taxol/Ridaforolimus in Endometrial, Ovarian and Solids |
https://ClinicalTrials.gov/show/NCT01256268 |
Completed |
H. Lee Moffitt Cancer Center and Research Institute |
2016-02-03 |
| NCT01244789 |
Chemotherapy or Observation in Stage I-II Intermediate or High Risk Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT01244789 |
Active, not recruiting |
Danish Gynecological Cancer Group |
2019-04-15 |
| NCT01237067 |
Olaparib in Combination With Carboplatin for Refractory or Recurrent Women s Cancers |
https://ClinicalTrials.gov/show/NCT01237067 |
Completed |
National Institutes of Health Clinical Center (CC) |
2014-11-16 |
| NCT01226316 |
Safety, Tolerability & Potential Anti-cancer Activity of Increasing Doses of AZD5363 in Different Treatment Schedules |
https://ClinicalTrials.gov/show/NCT01226316 |
Active, not recruiting |
AstraZeneca |
2019-04-26 |
| NCT01209195 |
A Study of MM-121 in Combination With Paclitaxel in Patients With Advanced Gynecologic and Breast Cancers |
https://ClinicalTrials.gov/show/NCT01209195 |
Completed |
Merrimack Pharmaceuticals |
2014-05-31 |
| NCT01205672 |
Evaluation of the Molecular Effects of Metformin on the Endometrium in Patients With Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT01205672 |
Completed |
M.D. Anderson Cancer Center |
2017-05-28 |
| NCT01198184 |
Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 and Temsirolimus in Treating Patients With Advanced Solid Tumors |
https://ClinicalTrials.gov/show/NCT01198184 |
Completed |
National Cancer Institute (NCI) |
2013-07-31 |
| NCT01185626 |
ROGYcare: The Impact of a Cancer Survivorship Care Plan on Patient Reported Outcomes and Health Care Providers |
https://ClinicalTrials.gov/show/NCT01185626 |
Completed |
University of Tilburg |
2016-07-31 |
| NCT01155258 |
Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors |
https://ClinicalTrials.gov/show/NCT01155258 |
Completed |
University of Southern California |
2013-01-31 |
| NCT01111461 |
Study of Lenvatinib in Subjects With Advanced Endometrial Cancer and Disease Progression |
https://ClinicalTrials.gov/show/NCT01111461 |
Completed |
Eisai Inc. |
2012-05-31 |
| NCT01079832 |
Stereotactic Radiosurgery Using CyberKnife in Treating Women With Advanced or Recurrent Gynecological Malignancies |
https://ClinicalTrials.gov/show/NCT01079832 |
Completed |
Case Comprehensive Cancer Center |
2012-05-31 |
| NCT01068483 |
Safety of BKM120 Monotherapy in Advanced Solid Tumor Patients |
https://ClinicalTrials.gov/show/NCT01068483 |
Completed |
Novartis |
2011-09-30 |
| NCT01068249 |
Letrozole and RAD001 With Advanced or Recurrent Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT01068249 |
Active, not recruiting |
M.D. Anderson Cancer Center |
2021-04-30 |
| NCT01065662 |
AZD2171 and Temsirolimus in Patients With Advanced Gynecological Malignancies |
https://ClinicalTrials.gov/show/NCT01065662 |
Active, not recruiting |
Dana-Farber Cancer Institute |
2013-09-30 |
| NCT01045187 |
Feasibility Study Using the Xoft System for the Treatment of Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT01045187 |
Completed |
Xoft, Inc. |
2010-01-31 |
| NCT01013324 |
Study of XL147 (SAR245408) in Advanced or Recurrent Endometrial Carcinoma |
https://ClinicalTrials.gov/show/NCT01013324 |
Completed |
Sanofi |
2013-03-31 |
| NCT01005329 |
Intensity-Modulated Radiation Therapy, Cisplatin, and Bevacizumab Followed by Carboplatin and Paclitaxel in Treating Patients Who Have Undergone Surgery for Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT01005329 |
Completed |
National Cancer Institute (NCI) |
2012-06-30 |
| NCT00997373 |
Letrozole as a Treatment of Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT00997373 |
Completed |
University of California, Davis |
2013-09-30 |
| NCT00987051 |
Sentinel Node and Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT00987051 |
Completed |
Assistance Publique - Hôpitaux de Paris |
2009-12-31 |
| NCT00977574 |
Paclitaxel, Carboplatin, and Bevacizumab or Paclitaxel, Carboplatin, and Temsirolimus or Ixabepilone, Carboplatin, and Bevacizumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT00977574 |
Active, not recruiting |
National Cancer Institute (NCI) |
2015-01-31 |
| NCT00924027 |
A Study of Patients Receiving High-Dose Rate Brachytherapy |
https://ClinicalTrials.gov/show/NCT00924027 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
2024-11-01 |
| NCT00916708 |
Trial Between Two Follow up Regimens With Different Test Intensity in Endometrial Cancer Treated Patients |
https://ClinicalTrials.gov/show/NCT00916708 |
Active, not recruiting |
Azienda Ospedaliera San Giovanni Battista |
2018-07-31 |
| NCT00910091 |
The Study of Oral Steroid Sulphatase Inhibitor BN83495 Versus Megestrol Acetate (MA) in Women With Advanced or Recurrent Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT00910091 |
Completed |
Ipsen |
2012-01-31 |
| NCT00879359 |
Trial of Vascular Endothelial Growth Factor (VEGF), Bevacizumab, in Combination With Cytotoxic Chemotherapy for Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT00879359 |
Completed |
The Cleveland Clinic |
2012-02-29 |
| NCT00870337 |
Everolimus in Treating Patients With Relapsed or Metastatic Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT00870337 |
Completed |
ARCAGY/ GINECO GROUP |
2011-05-31 |
| NCT00859768 |
The Effectiveness of the Screening Inventory of Psychosocial Problems (SIPP) in Cancer Patients |
https://ClinicalTrials.gov/show/NCT00859768 |
Completed |
Netherlands Open University |
2010-10-31 |
| NCT00842452 |
Topotecan in Treating Patients With Gynecologic Cancer That Cannot Be Removed by Surgery |
https://ClinicalTrials.gov/show/NCT00842452 |
Completed |
Case Comprehensive Cancer Center |
2011-04-30 |
| NCT04237090 |
Feasibility of a Clinical Trial Comparing the Use of Cetirizine to Replace Diphenhydramine in the Prevention of Reactions Related to Paclitaxel |
https://ClinicalTrials.gov/show/NCT04237090 |
Recruiting |
Ciusss de L’Est de l’ÃŽle de Montréal |
2020-09-30 |
| NCT03932409 |
Frontline Immunotherapy Combined With Radiation and Chemotherapy in High Risk Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT03932409 |
Recruiting |
University of Oklahoma |
2022-08-31 |
| NCT02466061 |
TREC Lifestyle Beyond Cancer Study in Endometrial Cancer Survivors |
https://ClinicalTrials.gov/show/NCT02466061 |
Completed |
Fred Hutchinson Cancer Research Center |
2016-06-30 |
| NCT01679483 |
Efficacy Study of FloSeal for Prevention of Lymphocele After Lymphadenectomy for Gynecologic Cancer |
https://ClinicalTrials.gov/show/NCT01679483 |
Completed |
Asan Medical Center |
2015-11-30 |
| NCT01918124 |
A Phase II Trial of Adjuvant Radiotherapy Combined With Chemotherapy for Patients With High-risk Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT01918124 |
Completed |
Fudan University |
2013-01-31 |
| NCT03835819 |
A Phase 2 Study of Mirvetuximab Soravtansine (IMGN853) and Pembrolizumab in Endometrial Cancer (EC) |
https://ClinicalTrials.gov/show/NCT03835819 |
Recruiting |
Dana-Farber Cancer Institute |
2021-10-01 |
| NCT02465541 |
Gentle Yoga and Dietary Counseling in Improving Physical Function and Quality of Life in Stage I-II Endometrial Cancer Survivors |
https://ClinicalTrials.gov/show/NCT02465541 |
Active, not recruiting |
Ohio State University Comprehensive Cancer Center |
2014-06-10 |
| NCT01672892 |
Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer |
https://ClinicalTrials.gov/show/NCT01672892 |
Active, not recruiting |
Radiation Therapy Oncology Group |
2015-12-31 |
| NCT03981796 |
A Study to Evaluate Dostarlimab Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Participants With Recurrent or Primary Advanced Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT03981796 |
Recruiting |
Tesaro, Inc. |
2021-10-11 |
| NCT03169023 |
Scale Down for Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT03169023 |
Completed |
Washington University School of Medicine |
2019-02-03 |
| NCT03016338 |
Study of Niraparib and TSR-042 in Recurrent Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT03016338 |
Recruiting |
University Health Network, Toronto |
2022-03-31 |
| NCT02690259 |
Sentinel Lymph Node Detection in Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT02690259 |
Completed |
Region Skane |
2018-05-30 |
| NCT03884101 |
Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) Versus Chemotherapy for Endometrial Carcinoma (ENGOT-en9 / MK-7902-001) |
https://ClinicalTrials.gov/show/NCT03884101 |
Recruiting |
Merck Sharp & Dohme Corp. |
2023-04-10 |
| NCT03694834 |
Window of Opportunity Study of Pembrolizumab in Early Stage, High Grade Obesity-driven Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT03694834 |
Recruiting |
UNC Lineberger Comprehensive Cancer Center |
2022-05-01 |
| NCT02035787 |
Metformin With the Levonorgestrel-Releasing Intrauterine Device for the Treatment of Complex Atypical Hyperplasia (CAH) and Endometrial Cancer (EC) in Non-surgical Patients |
https://ClinicalTrials.gov/show/NCT02035787 |
Recruiting |
UNC Lineberger Comprehensive Cancer Center |
2022-12-31 |
| NCT01806350 |
Pelvic Floor Muscle Training in Treating Urinary Incontinence in Gynecologic Cancer Survivors |
https://ClinicalTrials.gov/show/NCT01806350 |
Completed |
New Mexico Cancer Care Alliance |
2012-09-30 |
| NCT03926936 |
FUlvestrant in Gynecological Cancers That Are Potentially Hormone Sensitive: the FUCHSia Study |
https://ClinicalTrials.gov/show/NCT03926936 |
Recruiting |
University Hospital, Gasthuisberg |
2022-04-01 |
| NCT00770185 |
Ridaforolimus in Treating Patients With Recurrent Metastatic and/or Locally Advanced Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT00770185 |
Completed |
Canadian Cancer Trials Group |
2012-03-19 |
| NCT00756847 |
Safety Study of XL147 (SAR245408), in Combination With Paclitaxel and Carboplatin in Adults With Solid Tumors |
https://ClinicalTrials.gov/show/NCT00756847 |
Completed |
Sanofi |
2012-05-31 |
| NCT00739830 |
Clinical Trial of Ridaforolimus Compared to Progestin or Chemotherapy for Advanced Endometrial Carcinoma (MK-8669-007 AM6) |
https://ClinicalTrials.gov/show/NCT00739830 |
Completed |
Merck Sharp & Dohme Corp. |
2011-02-28 |
| NCT00732173 |
Exercise and Healthy Diet or Standard Care in Patients in Remission From Stage I or Stage II Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT00732173 |
Completed |
Case Comprehensive Cancer Center |
2010-03-31 |
| NCT00729586 |
Temsirolimus With or Without Megestrol Acetate and Tamoxifen Citrate in Treating Patients With Advanced, Persistent, or Recurrent Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT00729586 |
Completed |
National Cancer Institute (NCI) |
2017-02-28 |
| NCT00723255 |
Bevacizumab and Temsirolimus in Treating Patients With Recurrent or Persistent Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT00723255 |
Completed |
National Cancer Institute (NCI) |
2011-07-15 |
| NCT00703807 |
Study of the Weekly Oral RAD001 in Combination With Oral Topotecan in Patients With Advanced or Recurrent Endometrial Cancers |
https://ClinicalTrials.gov/show/NCT00703807 |
Completed |
Yale University |
2010-05-31 |
| NCT00659568 |
Metformin and Temsirolimus in Treating Patients With Metastatic or Unresectable Solid Tumor or Lymphoma |
https://ClinicalTrials.gov/show/NCT00659568 |
Completed |
National Cancer Institute (NCI) |
2010-02-28 |
| NCT00612495 |
Endometrial Cancer - LOHP Alone and With 5FU |
https://ClinicalTrials.gov/show/NCT00612495 |
Completed |
Sanofi |
NA |
| NCT00610740 |
CerviPrep for Applying Topical Gemcitabine to the Cervix in Treating Patients With Primary Endometrial, Cervical, or Ovarian Epithelial Cancer |
https://ClinicalTrials.gov/show/NCT00610740 |
Completed |
Masonic Cancer Center, University of Minnesota |
2008-04-30 |
| NCT00607607 |
A Phase 2 Study of Oral MKC-1 in Patients With Ovarian or Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT00607607 |
Completed |
CASI Pharmaceuticals, Inc. |
2011-06-30 |
| NCT00595725 |
Intra-Operative Lymphatic Mapping in Patients With Invasive Carcinoma of the Cervix or Endometrial Carcinoma |
https://ClinicalTrials.gov/show/NCT00595725 |
Completed |
Memorial Sloan Kettering Cancer Center |
2011-09-30 |
| NCT00575952 |
Intraperitoneal Paclitaxel, Doxorubicin Hydrochloride, and Cisplatin in Treating Patients With Stage III-IV Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT00575952 |
Completed |
Gynecologic Oncology Group |
2016-07-16 |
| NCT00569257 |
Antitumoral Activity and Safety of AEZS-108 in Women With LHRH Receptor Positive Gynecological Tumors |
https://ClinicalTrials.gov/show/NCT00569257 |
Completed |
AEterna Zentaris |
2011-07-31 |
| NCT00545792 |
Safety Study Of Avastin And Pelvic Radiation In Women With Recurrent Gynecological Cancers |
https://ClinicalTrials.gov/show/NCT00545792 |
Completed |
Dana-Farber Cancer Institute |
2010-11-30 |
| NCT00542490 |
Vaginal Cuff Brachytherapy Followed by Chemotherapy in Patients With Endometrioid Cancer |
https://ClinicalTrials.gov/show/NCT00542490 |
Completed |
University of Oklahoma |
2016-02-29 |
| NCT00526149 |
BI 2536 in Treating Patients With Recurrent or Metastatic Solid Tumors |
https://ClinicalTrials.gov/show/NCT00526149 |
Completed |
European Organisation for Research and Treatment of Cancer - EORTC |
2008-09-30 |
| NCT00515073 |
Papillary Serous Carcinoma of the Endometrium |
https://ClinicalTrials.gov/show/NCT00515073 |
Completed |
M.D. Anderson Cancer Center |
2013-05-31 |
| NCT00513786 |
Evaluation of Carboplatin/Paclitaxel/Bevacizumab in the Treatment of Advanced Stage Endometrial Carcinoma |
https://ClinicalTrials.gov/show/NCT00513786 |
Completed |
Ohio State University Comprehensive Cancer Center |
2017-01-03 |
| NCT00507741 |
Study of Vintafolide (MK-8109, EC145) in Participants With Advanced Ovarian and Endometrial Cancers (MK-8109-007, EC-FV-02) |
https://ClinicalTrials.gov/show/NCT00507741 |
Completed |
Endocyte |
2009-04-30 |
| NCT00505739 |
Mifepristone for Patients With Endometrial Cancer and LGESS |
https://ClinicalTrials.gov/show/NCT00505739 |
Completed |
M.D. Anderson Cancer Center |
2007-10-31 |
| NCT00483327 |
Management of Atypical Endometrial Hyperplasia and Endometrial Carcinoma Using Megestrol Acetate |
https://ClinicalTrials.gov/show/NCT00483327 |
Completed |
NYU Langone Health |
2013-10-31 |
| NCT00482300 |
Systematic Pelvic Lymphadenectomy Versus no Lymphadenectomy in Clinical Stage I-II Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT00482300 |
Completed |
University of Roma La Sapienza |
NA |
| NCT00474994 |
Sunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent Sarcomas |
https://ClinicalTrials.gov/show/NCT00474994 |
Completed |
Memorial Sloan Kettering Cancer Center |
2010-11-30 |
| NCT00462969 |
Cytologic Analysis of Distention Media as a Screening Test for Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT00462969 |
Completed |
University of Wisconsin, Madison |
2010-09-30 |
| NCT00462826 |
VEGF Trap in Treating Patients With Recurrent or Persistent Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT00462826 |
Completed |
National Cancer Institute (NCI) |
2013-01-31 |
| NCT00448643 |
Whole-Abdominal Radiation Therapy and Cisplatin in Treating Patients With Stage III or Stage IV Endometrial Cancer That Has Been Removed by Surgery |
https://ClinicalTrials.gov/show/NCT00448643 |
Completed |
University of Miami |
2011-03-31 |
| NCT00423254 |
Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer. |
https://ClinicalTrials.gov/show/NCT00423254 |
Completed |
Mannkind Corporation |
2009-09-30 |
| NCT00416455 |
Fludeoxyglucose (FDG) F 18 PET Scan, CT Scan, and Ferumoxtran-10 MRI Scan Before Chemotherapy and Radiation Therapy in Finding Lymph Node Metastasis in Patients With Locally Advanced Cervical Cancer or High-Risk Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT00416455 |
Completed |
National Cancer Institute (NCI) |
2014-09-30 |
| NCT00411138 |
Randomized Trial of Radiation Therapy With or Without Chemotherapy for Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT00411138 |
Active, not recruiting |
Leiden University Medical Center |
2018-11-29 |
| NCT00408655 |
Temsirolimus, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid Tumors |
https://ClinicalTrials.gov/show/NCT00408655 |
Completed |
National Cancer Institute (NCI) |
2012-01-31 |
| NCT00401635 |
END-1: First Line Chemotherapy for Advanced or Recurrent Endometrial Carcinoma With Carboplatin and Liposomal Doxorubicin |
https://ClinicalTrials.gov/show/NCT00401635 |
Completed |
National Cancer Institute, Naples |
NA |
| NCT00392769 |
Cetuximab in Patients With Progressive or Recurrent Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT00392769 |
Completed |
M.D. Anderson Cancer Center |
2010-12-31 |
| NCT00388154 |
Gemcitabine and Cisplatin for Advanced or Recurrent Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT00388154 |
Completed |
M.D. Anderson Cancer Center |
2013-11-30 |
| NCT00381888 |
Fondaparinux in Preventing Blood Clots in Patients Undergoing Surgery for Gynecologic Cancer |
https://ClinicalTrials.gov/show/NCT00381888 |
Completed |
Masonic Cancer Center, University of Minnesota |
2009-01-31 |
| NCT00377520 |
A Trial for Patients With Advanced/Recurrent Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT00377520 |
Completed |
Eli Lilly and Company |
2007-10-31 |
| NCT00376844 |
External-Beam Radiation Therapy Compared With Vaginal Brachytherapy After Surgery for Stage I Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT00376844 |
Completed |
Leiden University Medical Center |
2009-05-31 |
| NCT00334321 |
Pelvic IMRT With Tomotherapy in Post-Hysterectomy Endometrial Cancer Patients |
https://ClinicalTrials.gov/show/NCT00334321 |
Completed |
Washington University School of Medicine |
2011-04-30 |
| NCT00334295 |
Fulvestrant for the Treatment of Recurrent or Metastatic Endometrial Carcinoma. |
https://ClinicalTrials.gov/show/NCT00334295 |
Completed |
AstraZeneca |
2011-01-31 |
| NCT00333086 |
A Study of Letrozole in the Treatment of Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT00333086 |
Completed |
Novartis |
2006-06-30 |
| NCT00331760 |
Intensity-Modulated Radiation Therapy to the Pelvis With or Without Chemotherapy in Treating Patients With Endometrial Cancer or Cervical Cancer That Has Been Removed By Surgery |
https://ClinicalTrials.gov/show/NCT00331760 |
Completed |
Radiation Therapy Oncology Group |
2009-02-28 |
| NCT00319748 |
Study of Immune Response Modifier in the Treatment of Breast, Ovarian, Endometrial and Cervical Cancers |
https://ClinicalTrials.gov/show/NCT00319748 |
Completed |
Masonic Cancer Center, University of Minnesota |
2007-12-31 |
| NCT00315861 |
Topotecan in Combination With Pemetrexed in Patients With Advanced Malignancies |
https://ClinicalTrials.gov/show/NCT00315861 |
Completed |
SCRI Development Innovations, LLC |
2008-05-31 |
| NCT00301964 |
Bevacizumab in Treating Patients With Recurrent or Persistent Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT00301964 |
Completed |
National Cancer Institute (NCI) |
2011-07-31 |
| NCT00287885 |
Docetaxel in Treating Patients With Refractory or Recurrent Advanced Gynecologic Cancer |
https://ClinicalTrials.gov/show/NCT00287885 |
Completed |
Masonic Cancer Center, University of Minnesota |
2008-12-31 |
| NCT00268918 |
Docetaxel and PTK787 in Metastatic Breast Cancer Patients and Gynecological Cancer Patients |
https://ClinicalTrials.gov/show/NCT00268918 |
Completed |
Dana-Farber Cancer Institute |
2007-01-31 |
| NCT00267488 |
Intravenous Weekly Topotecan In Subjects With Recurrent Or Persistent Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT00267488 |
Completed |
GlaxoSmithKline |
2007-12-31 |
| NCT00262938 |
Lifestyle Change and Quality of Life in Obese Patients With Stage I/II Endometrial Cancer in Remission |
https://ClinicalTrials.gov/show/NCT00262938 |
Completed |
Case Comprehensive Cancer Center |
2006-01-31 |
| NCT00258362 |
Carboplatin, Docetaxel, and Radiation Therapy in Treating Patients With Stage III/IV, or Recurrent Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT00258362 |
Completed |
Masonic Cancer Center, University of Minnesota |
2009-12-31 |
| NCT00249990 |
Phase II Study of Aerosolized Liposomal 9-Nitro-20 (S)- Camptothecin (L9NC) |
https://ClinicalTrials.gov/show/NCT00249990 |
Completed |
University of New Mexico |
2006-07-31 |
| NCT00247923 |
Endometrial Polyps: Pathophysiology and Clinical Consequences |
https://ClinicalTrials.gov/show/NCT00247923 |
Completed |
Oslo University Hospital |
NA |
| NCT00245050 |
Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Liposomal Doxorubicin for Cancer |
https://ClinicalTrials.gov/show/NCT00245050 |
Completed |
Case Comprehensive Cancer Center |
2008-04-30 |
| NCT00205023 |
Disseminated Endometrial Cancer Cells During Sonohysterography |
https://ClinicalTrials.gov/show/NCT00205023 |
Completed |
University of Wisconsin, Madison |
2006-02-28 |
| NCT00190697 |
A Study of LY353381 (Arzoxifene) for Patients Who Benefitted From This Drug in Other Oncology Trials and Wished to Continue Treatment |
https://ClinicalTrials.gov/show/NCT00190697 |
Completed |
Eli Lilly and Company |
NA |
| NCT00171808 |
Letrozole in the Treatment of Advanced or Recurrent Hormone Receptor Positive Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT00171808 |
Completed |
Novartis |
2010-05-31 |
| NCT00134316 |
Cervical or Endometrial Cancer and Sexual Health Study |
https://ClinicalTrials.gov/show/NCT00134316 |
Completed |
University of British Columbia |
2009-11-30 |
| NCT00122343 |
AP23573 in Female Adult Patients With Recurrent or Persistent Endometrial Cancer (8669-019)(COMPLETED) |
https://ClinicalTrials.gov/show/NCT00122343 |
Completed |
Merck Sharp & Dohme Corp. |
2008-01-31 |
| NCT00107445 |
EF5 in Finding Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Cervical, Endometrial, or Ovarian Epithelial Cancer |
https://ClinicalTrials.gov/show/NCT00107445 |
Completed |
National Cancer Institute (NCI) |
2005-09-30 |
| NCT00099008 |
Genistein in Preventing Breast or Endometrial Cancer in Healthy Postmenopausal Women |
https://ClinicalTrials.gov/show/NCT00099008 |
Completed |
UNC Lineberger Comprehensive Cancer Center |
2005-07-31 |
| NCT00096447 |
Lapatinib in Treating Patients With Recurrent or Persistent Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT00096447 |
Completed |
National Cancer Institute (NCI) |
2011-03-31 |
| NCT00096408 |
Laparoscopic Approach to Cancer of the Endometrium |
https://ClinicalTrials.gov/show/NCT00096408 |
Completed |
Queensland Centre for Gynaecological Cancer |
2016-04-30 |
| NCT00095979 |
Ixabepilone in Treating Patients With Recurrent or Persistent Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT00095979 |
Completed |
National Cancer Institute (NCI) |
2009-07-31 |
| NCT00004915 |
Raloxifene in Treating Patients With Persistent or Recurrent Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT00004915 |
Completed |
Northwestern University |
2000-02-29 |
| NCT00002493 |
Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Advanced Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT00002493 |
Completed |
Gynecologic Oncology Group |
2001-04-30 |
| NCT00003267 |
Pelvic Drains After Radical Hysterectomy in Treating Patients With Uterine, Cervical, or Vaginal Cancer |
https://ClinicalTrials.gov/show/NCT00003267 |
Completed |
European Organisation for Research and Treatment of Cancer - EORTC |
2000-07-31 |
| NCT00087685 |
RAD001 in Recurrent Endometrial Cancer Patients |
https://ClinicalTrials.gov/show/NCT00087685 |
Completed |
M.D. Anderson Cancer Center |
2015-01-31 |
| NCT00087100 |
Pemetrexed Disodium in Treating Patients With Persistent or Recurrent Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT00087100 |
Completed |
Gynecologic Oncology Group |
2007-08-31 |
| NCT00003946 |
Danazol in Treating Patients With Advanced or Recurrent Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT00003946 |
Completed |
Gynecologic Oncology Group |
2003-06-30 |
| NCT00003691 |
Combination Chemotherapy With or Without G-CSF in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT00003691 |
Completed |
Gynecologic Oncology Group |
2004-06-30 |
| NCT00003127 |
S9720 Combination Chemotherapy in Treating Patients With Metastatic, Recurrent, or Refractory Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT00003127 |
Completed |
Southwest Oncology Group |
2003-04-30 |
| NCT00004251 |
Letrozole in Treating Women With Recurrent or Metastatic Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT00004251 |
Completed |
Canadian Cancer Trials Group |
2002-09-13 |
| NCT00002949 |
Vinorelbine and Paclitaxel Plus Radiation Therapy in Treating Patients With Advanced Cancer Arising in the Pelvis |
https://ClinicalTrials.gov/show/NCT00002949 |
Completed |
University of Chicago |
2000-11-30 |
| NCT00085332 |
Docetaxel in Treating Patients With Recurrent or Persistent Endometrial Carcinoma (Cancer) |
https://ClinicalTrials.gov/show/NCT00085332 |
Completed |
Gynecologic Oncology Group |
2005-12-31 |
| NCT00003939 |
Ecteinascidin 743 in Treating Patients With Advanced Soft Tissue Sarcoma |
https://ClinicalTrials.gov/show/NCT00003939 |
Completed |
European Organisation for Research and Treatment of Cancer - EORTC |
2000-11-30 |
| NCT00003669 |
Hormone Therapy With Arzoxifene Hydrochloride in Treating Women With Recurrent, Advanced, or Metastatic Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT00003669 |
Completed |
Eli Lilly and Company |
NA |
| NCT00006357 |
STI571 in Treating Patients With Recurrent or Refractory Soft Tissue Sarcoma |
https://ClinicalTrials.gov/show/NCT00006357 |
Completed |
European Organisation for Research and Treatment of Cancer - EORTC |
2001-04-30 |
| NCT00002764 |
Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue Sarcoma |
https://ClinicalTrials.gov/show/NCT00002764 |
Completed |
European Organisation for Research and Treatment of Cancer - EORTC |
2000-11-30 |
| NCT00005643 |
Chemotherapy in Treating Patients With Sarcoma of the Uterus |
https://ClinicalTrials.gov/show/NCT00005643 |
Completed |
Gynecologic Oncology Group |
2005-03-31 |
| NCT00004082 |
Combination Chemotherapy in Treating Patients With Previously Untreated, Newly Diagnosed Epithelial Tumors |
https://ClinicalTrials.gov/show/NCT00004082 |
Completed |
National Cancer Institute (NCI) |
2003-09-30 |
| NCT00005031 |
Irofulven in Treating Patients With Persistent or Recurrent, Refractory Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT00005031 |
Completed |
Gynecologic Oncology Group |
2004-10-31 |
| NCT00002459 |
Radiation Therapy or No Further Treatment Following Surgery in Treating Patients With Cancer of the Uterus |
https://ClinicalTrials.gov/show/NCT00002459 |
Completed |
European Organisation for Research and Treatment of Cancer - EORTC |
2001-08-31 |
| NCT00003334 |
Combination Chemotherapy in Treating Patients With Endometrial Cancer, Fallopian Tube Cancer, or Sarcoma of the Female Reproductive Tract |
https://ClinicalTrials.gov/show/NCT00003334 |
Completed |
NYU Langone Health |
2001-12-31 |
| NCT00072176 |
Temsirolimus in Treating Patients With Metastatic or Locally Advanced Recurrent Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT00072176 |
Completed |
National Cancer Institute (NCI) |
2009-05-31 |
| NCT00071929 |
Oxaliplatin in Treating Patients With Persistent or Recurrent Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT00071929 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00004074 |
Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu |
https://ClinicalTrials.gov/show/NCT00004074 |
Completed |
National Cancer Institute (NCI) |
2009-02-28 |
| NCT00025467 |
Thalidomide in Treating Patients With Recurrent or Persistent Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT00025467 |
Completed |
National Cancer Institute (NCI) |
2007-07-31 |
| NCT00063999 |
Doxorubicin Hydrochloride, Cisplatin, and Paclitaxel or Carboplatin and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT00063999 |
Active, not recruiting |
Gynecologic Oncology Group |
2013-06-29 |
| NCT00006377 |
Doxorubicin, Paclitaxel, and Carboplatin in Treating Patients With Primary Stage III, Stage IV, or Recurrent Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT00006377 |
Completed |
Memorial Sloan Kettering Cancer Center |
2003-01-31 |
| NCT00005861 |
Liposomal Doxorubicin in Treating Patients With Advanced or Recurrent Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT00005861 |
Completed |
Gynecologic Oncology Group |
2005-08-31 |
| NCT00053794 |
Perifosine in Treating Patients With Metastatic or Locally Advanced Soft Tissue Sarcoma |
https://ClinicalTrials.gov/show/NCT00053794 |
Completed |
Canadian Cancer Trials Group |
2004-09-18 |
| NCT00052312 |
Doxorubicin and Cisplatin With or Without Paclitaxel in Treating Patients With Locally Advanced, Metastatic, and/or Relapsed Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT00052312 |
Completed |
European Organisation for Research and Treatment of Cancer - EORTC |
2006-09-30 |
| NCT00033605 |
Octreotide in Preventing Diarrhea in Patients Who Are Undergoing Radiation Therapy to the Pelvis |
https://ClinicalTrials.gov/show/NCT00033605 |
Completed |
Alliance for Clinical Trials in Oncology |
2006-07-31 |
| NCT00033358 |
Hormone Therapy in Preventing Endometrial Cancer in Patients With a Genetic Risk For Hereditary Nonpolyposis Colon Cancer |
https://ClinicalTrials.gov/show/NCT00033358 |
Completed |
National Cancer Institute (NCI) |
2007-10-31 |
| NCT00032162 |
Liposomal Doxorubicin and Carboplatin in Treating Patients With Gynecologic Cancer |
https://ClinicalTrials.gov/show/NCT00032162 |
Completed |
AGO Study Group |
2005-05-31 |
| NCT00031681 |
7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) |
https://ClinicalTrials.gov/show/NCT00031681 |
Completed |
National Cancer Institute (NCI) |
2011-01-31 |
| NCT00030485 |
Erlotinib in Treating Patients With Locally Advanced and/or Metastatic Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT00030485 |
Completed |
National Cancer Institute (NCI) |
2007-04-30 |
| NCT00028535 |
Interleukin-12, Paclitaxel, and Trastuzumab in Treating Patients With Solid Tumors |
https://ClinicalTrials.gov/show/NCT00028535 |
Completed |
National Cancer Institute (NCI) |
2009-02-28 |
| NCT00023894 |
Flavopiridol in Treating Patients With Recurrent or Persistent Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT00023894 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00022620 |
Paclitaxel in Treating Patients With Refractory or Recurrent Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT00022620 |
Completed |
European Organisation for Research and Treatment of Cancer - EORTC |
2002-10-31 |
| NCT00019331 |
Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid Tumors |
https://ClinicalTrials.gov/show/NCT00019331 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00006027 |
Comparison of Radiation Therapy With or Without Combination Chemotherapy Following Surgery in Treating Patients With Stage I or Stage II Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT00006027 |
Completed |
Radiation Therapy Oncology Group |
2004-06-30 |
| NCT00006005 |
Thalidomide in Treating Patients With Gynecologic Sarcomas |
https://ClinicalTrials.gov/show/NCT00006005 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00005840 |
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT00005840 |
Completed |
Gynecologic Oncology Group |
2009-07-31 |
| NCT00005583 |
Radiation Therapy With or Without Chemotherapy in Treating Patients With High-Risk Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT00005583 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00003749 |
Surgery With or Without Lymphadenectomy and Radiation Therapy in Treating Patients With Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT00003749 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00002920 |
S9630, Medroxyprogesterone in Treating Women With Breast Cancer |
https://ClinicalTrials.gov/show/NCT00002920 |
Completed |
Southwest Oncology Group |
2006-12-31 |
| NCT00002807 |
Radiation or Observation Only in Endometrial Cancer Who Have Undergone Surgery |
https://ClinicalTrials.gov/show/NCT00002807 |
Completed |
Canadian Cancer Trials Group |
2007-12-31 |
| NCT00002641 |
Surgery With or Without Chemotherapy in Treating Patients With Soft Tissue Sarcoma |
https://ClinicalTrials.gov/show/NCT00002641 |
Completed |
European Organisation for Research and Treatment of Cancer - EORTC |
2006-02-28 |
| NCT00050440 |
Phase 2 Study of ET-743 (Trabectedin) in Patients With Persistent or Recurrent Endometrial Carcinoma |
https://ClinicalTrials.gov/show/NCT00050440 |
Completed |
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. |
NA |
| NCT00010829 |
Macrobiotic Diet and Flax Seed: Effects on Estrogens, Phytoestrogens, & Fibrinolytic Factors |
https://ClinicalTrials.gov/show/NCT00010829 |
Completed |
National Center for Complementary and Integrative Health (NCCIH) |
NA |